| |
|
|
| |
|
 |
 |
¾àǰ°Ë»ö |
 |
ºÎÀÛ¿ë ¹× ´ëó¹ý |
|
|
|
|
|
 |
| |
|
¾ÈƼƮ·Òºó¥²ÁÖ500IU Antithrombin-III Human 500IU
|
|
Àü¹®ÀǾàǰ | ±Þ¿©
|
|
|
| |
 |
¾Ë¸²: |
µå·°ÀÎÆ÷¿¡¼´Â ÀǾàǰ ÀÎÅÍ³Ý ÆÇ¸Å¸¦ ÇÏÁö ¾Ê½À´Ï´Ù. |
|
|
|
Àü¹®/ÀÏ¹Ý |
Àü¹®
|
|
|
|
| ¹é»öÀÇ µ¢¾î¸® ¶Ç´Â °¡·ç°¡ ¹«»öÅõ¸íÇÑ ¹ÙÀ̾˿¡ µç ÁÖ»çÁ¦·Î ÷ºÎ¿ëÁ¦·Î ¿ëÇØÇÏ¸é ¹«»ö ¶Ç´Â ´ãȲ»öÀÇ Åõ¸íÇÑ ¾× |
|
|
|
|
Á¦Á¶È¸»ç |
(ÁÖ)³ì½ÊÀÚ
|
ÆÇ¸Åȸ»ç |
(ÁÖ)³ì½ÊÀÚ
|
Çã°¡Á¤º¸ |
Á¤»ó
(2004.11.15)
|
BIT ¾àÈ¿ºÐ·ù |
Ç×ÀÀ°íÁ¦ (Anticoagulants)
|
º¹ÁöºÎºÐ·ù |
634[Ç÷¾×Á¦Á¦·ù ] |
û±¸ÄÚµå(KDÄÚµå) ºñ±Þ¿©Á¡°ËÄÚµå |
643601351 \201,589 ¿ø/1º´(2017.02.01)(ÇöÀç¾à°¡)\201,589 ¿ø/1º´(2016.01.01)(º¯°æÀü¾à°¡)
|
|
|
ATCÄÚµå |
Antithrombin III / B01AB02 |
NDCÄÚµå |
[Proprietary Name Search _ ƯÇãµî·Ï¸í,»óÇ¥¸íÀ¸·Î °Ë»ö]
[Active Ingredient Search _ ÁÖ¼ººÐÀ¸·Î °Ë»ö]
[NDC Number Search _ NDCÄÚµå·Î °Ë»ö]
|
¼ººÐ / ÇÔ·® |
[½ÉÆò¿ø ÁÖ¼ººÐÄÚµå ±âÁØ ¼ººÐÇÔ·®Á¤º¸ Á¶È¸]

|
÷°¡Á¦ |
±Û¸®½Å,
¸ê±ÕÁÖ»çħ,
¼öµ¿½ÄÀǾàǰȥÇÕ¿ë±â±¸,
½ÃÆ®¸£»ê³ªÆ®·ý¼öȹ°,
¿°È³ªÆ®·ý,
ÁÖ»ç±â,
ÁÖ»ç¿ë¼ö,
Á÷Á¢ÁÖÀÔ¿ëÀǾàǰÁÖÀÔ¿ë±â±¸
|
|
|
|
|
 |
|
|
|
|
|
| Ç× ¸ñ |
³» ¿ë |
|
ºÎÀÛ¿ëºóµµ ¹× ´ëó¹ý |
[À¯·á] |
|
|
| |
ÃÖ±ÙÁ¤º¸¼öÁ¤ÀÏ 2025-11-03 |
|
|
|
|
| |
|
|
|
|